JP2003002819A - Skin care composition - Google Patents

Skin care composition

Info

Publication number
JP2003002819A
JP2003002819A JP2001189617A JP2001189617A JP2003002819A JP 2003002819 A JP2003002819 A JP 2003002819A JP 2001189617 A JP2001189617 A JP 2001189617A JP 2001189617 A JP2001189617 A JP 2001189617A JP 2003002819 A JP2003002819 A JP 2003002819A
Authority
JP
Japan
Prior art keywords
genus
glycosides
plants
ohdg
plants belonging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001189617A
Other languages
Japanese (ja)
Other versions
JP4901024B2 (en
Inventor
Hiroshi Tanaka
弘 田中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Naris Cosmetics Co Ltd
Original Assignee
Naris Cosmetics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naris Cosmetics Co Ltd filed Critical Naris Cosmetics Co Ltd
Priority to JP2001189617A priority Critical patent/JP4901024B2/en
Publication of JP2003002819A publication Critical patent/JP2003002819A/en
Application granted granted Critical
Publication of JP4901024B2 publication Critical patent/JP4901024B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain an 8-OHdG production inhibiting agent which can prevent or improve the formation of fine wrinkles and blots by restraining the production of 8-OHdG. SOLUTION: One or more 8-OHdG (8-hydroxydeoxyguanosine) production- inhibiting agents selected from the group consisting of a catechin and/or its glycosides, a flavone and/or its glycosides, a flavonol and/or its glycosides, a flavanone and/or its glycosides, an isoflavone and/or its glycosides, a coumarin and/or its glycosides and the extracts of plants selected from the genera Vitis, Plantago, Linum, Carthamus, Gossypium, Rosemary, Eucalyptus, Gnaphalium, Thymus, Syringa and Pinus and Banzakuro assort of pomegranate are characteristically compounded in cosmetics. The 8-OHdG production-inhibiting agent inhibits the production of 8-OHdG in DNA of cells by ultraviolet rays, and prevents or improves the formation of the fine wrinkles and blots.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、8-ハイドロキシデ
オキシグアノシン(以下8-OHdGと略)産生抑制作用を有
し、紫外線によるDNAの損傷を防ぐことによりシミ・シ
ワなどの皮膚の老化を予防または改善する化粧料に関す
る。
TECHNICAL FIELD The present invention has an inhibitory action on 8-hydroxydeoxyguanosine (hereinafter abbreviated as 8-OHdG) production and prevents skin aging such as spots and wrinkles by preventing DNA damage due to ultraviolet rays. Or to improve cosmetics.

【0002】[0002]

【従来の技術】皮膚の老化には紫外線が深く関与し、シ
ミ・シワの原因になっていると考えられる。すなわち、
メラニンが紫外線などの外的刺激を受けて肌の皮膚組織
で生産され、そのために肌の黒化が促進され、シミ、ソ
バカス色黒等の症状が引き起こされるものと考えられ
る。皮膚の線維芽細胞は紫外線により生じる活性酸素な
どによる傷害を受けて、コラーゲンやヒアルロン酸の産
生が抑制され、シワの原因になっている。肌の美白作用
の確認法としては、メラニンの生成に関与するチロシナ
ーゼの活性を抑制することが提案されている。従来、チ
ロシナーゼの活性を抑制する物質として、美白化粧料に
は、生薬などの天然物の抽出物が化粧料に配合されてき
た。また、アスコルビン酸誘導体、グルタチオン、コロ
イドイオウ等の化合物が配合されており、このような美
白化粧料は皮膚の色黒、シミ、ソバカスの防止など美容
効果を得るために利用されてきた。また、シワの予防改
善にはグリコール酸等のα-ヒドロキシ酸や、線維芽細
胞のコラーゲン産生促進作用のある生薬類が化粧料に配
合されてきた。
2. Description of the Related Art Ultraviolet rays are deeply involved in the aging of the skin and are considered to be the cause of spots and wrinkles. That is,
It is considered that melanin is produced in the skin tissue of the skin by external stimuli such as ultraviolet rays, which promotes blackening of the skin and causes symptoms such as spots and freckles. Skin fibroblasts are damaged by active oxygen generated by ultraviolet rays and the production of collagen and hyaluronic acid is suppressed, causing wrinkles. As a method for confirming the skin whitening effect, it has been proposed to suppress the activity of tyrosinase involved in the production of melanin. Conventionally, as a substance that suppresses the activity of tyrosinase, an extract of a natural product such as a crude drug has been blended into cosmetics for whitening cosmetics. In addition, compounds such as ascorbic acid derivatives, glutathione, and colloidal sulfur are blended, and such whitening cosmetics have been used to obtain cosmetic effects such as preventing dark skin, stains and freckles on the skin. Further, α-hydroxy acids such as glycolic acid and crude drugs having a collagen production promoting action on fibroblasts have been incorporated into cosmetics for the prevention and improvement of wrinkles.

【0003】[0003]

【発明が解決しようとする問題点】しかしながら、シミ
の改善を期待するアスコルビン酸誘導体は、それ自体が
酸化され易いため効果の発現が期待しにくいばかりか、
配合した化粧品が経時的に変色、変臭する。また、グル
タチオンやコロイドイオウは特有の臭気や安定性に問題
があり、製品化に支障があった。一方、生薬類は、安全
性が高いことからその有用性が期待されているものの、
その美白効果はいまだ不十分なものが多かった。さら
に、シワの改善を期待して配合されるグリコール酸等の
α-ヒドロキシ酸は皮膚刺激が強く、充分な量を配合す
ることが難しかった。
However, the ascorbic acid derivative, which is expected to improve spots, is not easily expected to exhibit its effect because it is easily oxidized.
The blended cosmetics change color and odor over time. In addition, glutathione and colloidal sulfur have problems with their unique odor and stability, which hinders their commercialization. On the other hand, crude drugs are expected to be useful because of their high safety,
The whitening effect was still insufficient in many cases. Further, α-hydroxy acids such as glycolic acid, which is added in the hope of improving wrinkles, has strong skin irritation and it has been difficult to add a sufficient amount.

【0004】[0004]

【課題を解決するための手段】本発明者は紫外線による
シミ・シワなどの皮膚の老化を予防改善するため鋭意研
究を進めた結果、紫外線による細胞のDNAの損傷を抑制
する事により、上記の目的を達成することが可能である
事を突き止めた。すなわち、紫外線により生じるDNA塩
基中の8-OHdGはメラノサイトに作用してメラニン産生
を促進する。よって、紫外線照射による8-OHdGの生成を
抑制することによりメラニン産生が抑制されることにな
る。また、8-OHdGの生成を抑制することは、それだけ細
胞のDNAの損傷を抑制することになり、線維芽細胞にお
いてはコラーゲンの産生が促進されることになり、シワ
の改善につながることを発見した。本発明者は、上記課
題を解決するために、種々の物質および植物抽出物につ
いて8-OHdG産生抑制効果を調べた結果、カテキン類およ
び/又はその配糖体、フラボン類および/又はその配糖
体、フラボノール類および/又はその配糖体、フラバノ
ン類および/又はその配糖体、イソフラボン類および/
又はその配糖体、クマリン類および/又はその配糖体、
ビチス(Vitis)属、プランタゴ(Plantago)属、リナ
ム(Linum)属、カーサマス(Carthamus)属、ゴシピウ
ム(Gossypium)属、ローズマリー(Rosmarinus)属、
バンザクロ(Psidium)属、ユーカリ(Eucalyptus)
属、グナファリウム(Gnaphalium)属、サイムス(Thym
us)属、シリンガ(Syringa)属、マツ(Pinus)属に属
する植物の抽出物に目的の効果を有することを見出し、
本発明を完成するに至った。
Means for Solving the Problems As a result of intensive research to prevent and improve skin aging such as spots and wrinkles due to ultraviolet rays, the present inventor has suppressed the DNA damage of cells due to ultraviolet rays to We have found that it is possible to achieve the purpose. That is, 8-OHdG in the DNA base generated by ultraviolet rays acts on melanocytes to promote melanin production. Therefore, melanin production is suppressed by suppressing the production of 8-OHdG by ultraviolet irradiation. It was also discovered that suppressing the production of 8-OHdG would suppress the damage of DNA in cells to that extent and promote the production of collagen in fibroblasts, leading to the improvement of wrinkles. did. The present inventor, in order to solve the above problems, as a result of examining the 8-OHdG production inhibitory effect on various substances and plant extracts, catechins and / or glycosides thereof, flavones and / or glycosides thereof Body, flavonols and / or glycosides thereof, flavanones and / or glycosides thereof, isoflavones and / or
Or a glycoside thereof, a coumarin and / or a glycoside thereof,
Vitis genus, Plantago genus, Linum genus, Carthamus genus, Gossypium genus, rosemary (Rosmarinus) genus,
Genus Psidium, Eucalyptus
Genus, Gnaphalium, Thym
It has been found that the extract of plants belonging to the genus us), genus Syringa and genus Pinus has a desired effect,
The present invention has been completed.

【0005】即ち、本発明はカテキン類および/又はそ
の配糖体、フラボン類および/又はその配糖体、フラボ
ノール類および/又はその配糖体、フラバノン類および
/又はその配糖体、イソフラボン類および/又はその配
糖体、クマリン類および/又はその配糖体、ビチス(Vi
tis)属、プランタゴ(Plantago)属、リナム(Linum)
属、カーサマス(Carthamus)属、ゴシピウム(Gossypi
um)属、ローズマリー(Rosmarinus)属、バンザクロ
(Psidium)属、ユーカリ(Eucalyptus)属、グナファ
リウム(Gnaphalium)属、サイムス(Thymus)属、シリ
ンガ(Syringa)属、マツ(Pinus)属に属する植物の抽
出物からなる群から選ばれる1種または2種以上の植物
の抽出物を有効成分として含有することを特徴とする8-
OHdG産生抑制剤を提供するものである。
That is, the present invention relates to catechins and / or glycosides thereof, flavones and / or glycosides thereof, flavonols and / or glycosides thereof, flavanones and / or glycosides thereof, isoflavones. And / or its glycoside, coumarins and / or its glycoside, Vitis (Vi
tis genus, Plantago genus, Linum
Genus, Carthamus, Gossypi
um), Rosemary (Rosmarinus), Pomedium (Psidium), Eucalyptus (Eucalyptus), Gnaphalium (Gnaphalium), Thymus (Thymus), Syringa (Syringa), and Pinus (Pinus) An extract containing one or more kinds of plants selected from the group consisting of extracts as an active ingredient 8-
An OHdG production inhibitor is provided.

【0006】本発明に用いることの出来る物質及び植物
抽出物は特に限定されないが、カテキン類および/又は
その配糖体にはカテキン、エピカテキン、エピガロカテ
キン、エピガロカテキンガレート等が挙げられる。
The substances and plant extracts that can be used in the present invention are not particularly limited, and catechins and / or glycosides thereof include catechin, epicatechin, epigallocatechin, epigallocatechin gallate and the like.

【0007】フラボン類および/又はその配糖体にはル
テオリン、フラボン、アピゲニン等が挙げられる。
Examples of flavones and / or their glycosides include luteolin, flavones and apigenin.

【0008】フラボノール類および/又はその配糖体に
はクエルセチン、ミリセチン、ケンフェロール、クエル
シトリン、ルチン等が挙げられる。
Examples of flavonols and / or their glycosides include quercetin, myricetin, kaempferol, quercitrin, rutin and the like.

【0009】フラバノン類および/又はその配糖体には
ナリンゲニン、ヘスペリジン、ナリンギン等が挙げられ
る。
Examples of flavanones and / or glycosides thereof include naringenin, hesperidin and naringin.

【0010】イソフラボン類および/又はその配糖体に
はゲニステイン、ダイゼイン、ゲニスチン等が挙げられ
る。
The isoflavones and / or their glycosides include genistein, daidzein, genistin and the like.

【0011】クマリン類および/又はその配糖体にはエ
スクレチン等が挙げられる。
Coumarins and / or glycosides thereof include esculetin and the like.

【0012】また、ビチス(Vitis)属植物としてブド
ウ(Vitis vinifera L.)等が挙げられる。
[0012] Examples of plants belonging to the genus Vitis include grapes (Vitis vinifera L.).

【0013】プランタゴ(Plantago)属植物としてオオ
バコ(Plantago major L. var. asiatica QECAISNE)、
エゾオオバコ(Plantago camtschatica Cham.Ex Lin
k)等が挙げられる。
Plantago genus plant (Plantago major L. var. Asiatica Q ECAISNE ),
Ezo plantain (Plantago camtschatica Cham.Ex Lin
k) and the like.

【0014】リナム(Linum)属植物として亜麻(Linum
usitatissimum L.)等が挙げられる。
As a plant of the genus Linum, flax (Linum)
usitatissimum L.) and the like.

【0015】カーサマス(Carthamus)属植物として紅
花(Carthamus tinctorius L.)等が挙げられる。
Examples of plants belonging to the genus Carthamus include safflower (Carthamus tinctorius L.).

【0016】ゴシピウム(Gossypium)属植物として綿
花(Gossypium herbaceumLINNAEUS)等が挙げられる。
Cotton (Gossypium herbaceumL INNAEUS ) and the like can be mentioned as a plant of the genus Gossypium.

【0017】ローズマリー(Rosmarinus)属に属する植
物としてローズマリー(Rosmarinus officinalis L.)
等が挙げられる。
As a plant belonging to the genus Rosemary (Rosmarinus), rosemary (Rosmarinus officinalis L.)
Etc.

【0018】バンジロウ(Psidium)属に属する植物と
してグアバ(Psidium guajava L.)等が挙げられる。
Examples of plants belonging to the genus Psidium include guava (Psidium guajava L.) and the like.

【0019】ユーカリ(Eucalyptus)属に属する植物と
してユーカリ(Eucalyptus globules LABILL.)等が挙
げられる。
Examples of plants belonging to the genus Eucalyptus include Eucalyptus globules L ABILL .

【0020】グナファリウム(Gnaphalium)属に属する
植物としてエバーラスティング(Gnaphalium uliginosu
m L.)等が挙げられる。
Everlasting (Gnaphalium uliginosu) is a plant belonging to the genus Gnaphalium.
m L.) and the like.

【0021】サイムス(Thymus)属に属する植物として
ワイルドタイム(Thymusserpyllum L.)、イブキジャコ
ウソウ(Thymus quinquecostatus Celak.)等が挙げ
られる。
[0021] Examples of plants belonging to the genus Thymus include wild thyme (Thymusserpyllum L.) and mussel (Thymus quinquecostatus Celak.).

【0022】シリンガ(Syringa)属に属する植物とし
てライラック(Syringa vulgaris)等が挙げられる。
Examples of plants belonging to the genus Syringa include lilac (Syringa vulgaris).

【0023】マツ(Pinus)属に属する植物として、フ
ランス海岸松(Pinus pinaster)等が挙げられる。
Examples of plants belonging to the genus Pinus include Pinus pinaster.

【0024】本発明に用いるカテキン類および/又はそ
の配糖体、フラボン類および/又はその配糖体、フラボ
ノール類および/又はその配糖体、フラバノン類および
/又はその配糖体、イソフラボン類および/又はその配
糖体、クマリン類および/又はその配糖体は、市販の試
薬を使用することが出来る。また、これらの化合物を多
く含有する植物から各種の溶媒、例えば、水;メチルア
ルコール、エチルアルコール等の低級1価アルコール;
グリセリン、プロピレングリコール、1,3−ブチレン
グリコール等の液状多価アルコール;アセトン、メチル
エチルケトン等のケトン;酢酸エチルなどのアルキルエ
ステル;ベンゼン、ヘキサン等の炭化水素;ジエチルエ
ーテル等のエーテル類;ジクロルメタン、クロロホルム
等のハロゲン化アルカン等の1種または2種以上を用い
て抽出し、精製して使用することが出来るし、化学的な
合成によっても上記化合物を作成したものを使用するこ
とも可能である。
Catechins and / or glycosides thereof, flavones and / or glycosides thereof, flavonols and / or glycosides thereof, flavanones and / or glycosides thereof, isoflavones and As the glycoside, the coumarin and / or the glycoside thereof, commercially available reagents can be used. In addition, various solvents such as water; lower monohydric alcohols such as methyl alcohol and ethyl alcohol, from plants containing a large amount of these compounds;
Liquid polyhydric alcohols such as glycerin, propylene glycol and 1,3-butylene glycol; ketones such as acetone and methyl ethyl ketone; alkyl esters such as ethyl acetate; hydrocarbons such as benzene and hexane; ethers such as diethyl ether; dichloromethane, chloroform It is possible to use by extracting with one or more kinds of halogenated alkanes and the like, and then purifying and using it, and it is also possible to use those prepared from the above compound by chemical synthesis.

【0025】また、ビチス(Vitis)属、プランタゴ(P
lantago)属、リナム(Linum)属、カーサマス(Cartha
mus)属、ゴシピウム(Gossypium)属、ローズマリー
(Rosmarinus)属、バンザクロ(Psidium)属、ユーカ
リ(Eucalyptus)属、グナファリウム(Gnaphalium)
属、サイムス(Thymus)属、シリンガ(Syringa)属、
マツ(Pinus)属に属する植物の使用部位は特に限定さ
れず、それぞれの葉、枝、茎、花、果実、根、種子等あ
るいは全草を生のまま或いは乾燥したものを用いて抽出
することが出来るが、就中、プランタゴ(Plantago)
属、リナム(Linum)属、カーサマス(Carthamus)属、
ゴシピウム(Gossypium)属は種子、マツ(Pinus)属は
樹皮が特に好適である。
[0025] Also, the genus Vitis, plantago (P
genus lantago, genus Linum, Cartha
genus mus), genus Gossypium, genus Rosemarinus, genus Psidium, eucalyptus, Gnaphalium
Genus, Thymus genus, Syringa genus,
The part to be used of the plant belonging to the genus Pinus is not particularly limited, and each leaf, branch, stem, flower, fruit, root, seed, etc. or whole grass should be extracted using raw or dried ones. You can, but above all, Plantago
Genus, Linum genus, Carthamus genus,
Seeds are particularly suitable for the genus Gossypium, and bark is particularly suitable for the genus Pinus.

【0026】植物抽出物の調製は特に限定されないが、
例えば種々の適当な有機溶媒を用いて低温下から加温下
で抽出することが出来る。抽出溶媒としては、例えば、
水;メチルアルコール、エチルアルコール等の低級1価
アルコール;グリセリン、プロピレングリコール、1,
3−ブチレングリコール等の液状多価アルコール;アセ
トン、メチルエチルケトン等のケトン;酢酸エチルなど
のアルキルエステル;ベンゼン、ヘキサン等の炭化水
素;ジエチルエーテル等のエーテル類;ジクロルメタ
ン、クロロホルム等のハロゲン化アルカン等の1種また
は2種以上を用いることが出来る。就中、水、エチルア
ルコール、1,3−ブチレングリコールの1種または2
種以上の混合溶媒が特に好適である。
The preparation of the plant extract is not particularly limited,
For example, various suitable organic solvents can be used for extraction from a low temperature to a high temperature. As the extraction solvent, for example,
Water; lower monohydric alcohols such as methyl alcohol and ethyl alcohol; glycerin, propylene glycol, 1,
Liquid polyhydric alcohols such as 3-butylene glycol; ketones such as acetone and methyl ethyl ketone; alkyl esters such as ethyl acetate; hydrocarbons such as benzene and hexane; ethers such as diethyl ether; halogenated alkanes such as dichloromethane and chloroform One kind or two or more kinds can be used. Among them, water, ethyl alcohol, 1,3-butylene glycol, one or two
Mixtures of one or more solvents are particularly suitable.

【0027】抽出方法としては特に限定されないが、各
植物を適当に細かく粉砕したものを例えば乾燥したもの
であれば、重量比で1〜1000倍量、特に10〜10
0倍量の溶媒を用い、常温抽出の場合には、0℃以上、
特に20℃〜40℃で1時間以上、特に3〜7日間行う
のが好ましい。また、60〜100℃で1時間、加熱抽
出しても良い。
The extraction method is not particularly limited, but if each plant is appropriately finely pulverized and dried, for example, it is 1 to 1000 times the weight ratio, particularly 10 to 10 times.
In the case of extraction at room temperature using 0 times the amount of solvent, 0 ° C or higher,
It is particularly preferable to carry out the treatment at 20 ° C. to 40 ° C. for 1 hour or longer, particularly 3 to 7 days. Moreover, you may heat-extract at 60-100 degreeC for 1 hour.

【0028】以上のような条件で得られる上記各抽出物
は、抽出された溶液のまま用いても良いが、さらに必要
により、濾過等の処理をして、濃縮、粉末化したものを
適宜使い分けて用いることが出来る。
Each of the above-mentioned extracts obtained under the above conditions may be used as it is as an extracted solution, but if necessary, it may be subjected to a treatment such as filtration, concentrated and powdered to be used properly. Can be used.

【0029】本発明の化粧料における抽出物の配合量
は、蒸発乾燥分に換算して0.00001〜20.0重
量%が好ましく、特に0.01〜10.0重量%の範囲
が最適である。
The amount of the extract compounded in the cosmetic composition of the present invention is preferably 0.00001 to 20.0% by weight in terms of evaporative dry matter, and most preferably 0.01 to 10.0% by weight. is there.

【0030】本発明の化粧料は、上記必須成分のほか、
水性成分、油性成分、植物抽出物、動物抽出物、粉末、
賦形剤、界面活性剤、油剤、アルコール、pH調整剤、
防腐剤、酸化防止剤、増粘剤、甘味剤、色素、香料等を
必要に応じて混合して適宜配合することにより調製され
る。本発明の化粧料の剤型は特に限定されず、化粧水、
乳液、クリーム、パック、パウダー、スプレー、軟膏、
分散液、洗浄料等種々の剤型とすることができる。
The cosmetic composition of the present invention comprises, in addition to the above essential ingredients,
Aqueous component, oil component, plant extract, animal extract, powder,
Excipients, surfactants, oils, alcohols, pH adjusters,
Preservatives, antioxidants, thickeners, sweeteners, dyes, flavors and the like are mixed as necessary and prepared. The dosage form of the cosmetic of the present invention is not particularly limited, and a lotion,
Emulsion, cream, pack, powder, spray, ointment,
It can be made into various dosage forms such as a dispersion and a cleaning agent.

【0031】[0031]

【実施例】以下、本発明による各種抽出物の8-OHdG産生
抑制効果にかかわる試験実施例を示すと共にその素材を
用いた化粧料への応用処方例等について述べるが、ここ
に記載された実施例に限定されないのは言うまでもな
い。
[Examples] Hereinafter, test examples relating to the 8-OHdG production inhibitory effect of various extracts according to the present invention will be shown, and examples of application prescriptions to cosmetics using the materials will be described. It goes without saying that it is not limited to the examples.

【0032】(1)試料溶液及び培養液の調製 試料溶液としては、カテキン、エピカテキン、エピガロ
カテキン、エピガロカテキンガレート、ルテオリン、フ
ラボン、アピゲニン、クエルセチン、ミリセチン、ケン
フェロール、クエルシトリン、ルチン、ナリンゲニン、
ヘスペリジン、ナリンギン、ゲニステイン、ダイゼイ
ン、ゲニスチン、エスクレチンは市販の購入試薬を用い
た。 ブドウ、オオバコ、エゾオオバコ、亜麻、紅花、
綿花は種子および、ローズマリー、グアバ、ユーカリ、
エバーラスティング、ワイルドタイム、イブキジャコウ
ソウ、ライラックは植物の全草、フランス海岸松の樹皮
を乾燥したものを粉末にし、50%エタノール水溶液で
37℃にて一週間侵漬抽出した。これら試薬および抽出
乾燥エキス100mgにジメチルスルホキシド(DMS
O)を500μl、PBS(−)9.5mlを加えて溶
解し試料溶液とした。
(1) Preparation of sample solution and culture solution As sample solutions, catechin, epicatechin, epigallocatechin, epigallocatechin gallate, luteolin, flavone, apigenin, quercetin, myricetin, kaempferol, quercitrin, rutin, Naringenin,
Commercially available purchased reagents were used for hesperidin, naringin, genistein, daidzein, genistin, and esculetin. Grapes, plantain, psyllium, flax, safflower,
Cotton seeds, rosemary, guava, eucalyptus,
For everlasting, wild thyme, mussels and lilac, dried plant bark and bark of French coastal pine were powdered and soaked and extracted with 50% ethanol aqueous solution at 37 ° C. for one week. Dimethyl sulfoxide (DMS) was added to 100 mg of these reagents and the dried extract.
500 μl of O) and 9.5 ml of PBS (−) were added and dissolved to prepare a sample solution.

【0033】(2)細胞の調製 細胞は人胎児皮膚ケラチノサイト(Clonetic社)を用い、
培地はsigma社のケラチノサイト用合成培地にて培養し
た。 直径8cmのシャーレ(50cm2)に人皮膚ケラチノサ
イト細胞をコンフルーエントになるまで培養した。有効
性を測定しようとするサンプルを、前もって測定した細
胞毒性のかからない濃度で添加し、3時間培養する。3時
間後、培地を除去し、PBS(-)溶液でよく洗浄した。洗浄
後、2mlのPBS(-)を添加し、細胞に20mJ/ cm2 の紫外線
を照射した。照射後、トリプシン処理により細胞をエッ
ペンドルフチューブに回収する。
(2) Preparation of cells Human fetal skin keratinocytes (Clonetic) were used as cells.
The medium was cultured in a synthetic medium for keratinocytes manufactured by sigma. Human skin keratinocyte cells were cultured in a petri dish (50 cm 2 ) having a diameter of 8 cm until confluent. The sample whose efficacy is to be measured is added at a pre-measured non-cytotoxic concentration and incubated for 3 hours. After 3 hours, the medium was removed and well washed with PBS (-) solution. After washing, 2 ml of PBS (-) was added, and the cells were irradiated with 20 mJ / cm 2 of ultraviolet light. After irradiation, the cells are collected in an Eppendorf tube by trypsinization.

【0034】(3)細胞からのDNA抽出 回収した細胞中のDNAを和光純薬工業株式会社のDNAExtr
actor WB kitにより抽出した。抽出物に蒸留水75μl加
え、4℃で1昼夜放置した。その後、溶液を95℃、5分間
加熱後、素早く急冷し、2M-酢酸ナトリウム緩衝液(PH4.
5)1μl、nucleaseP1 5μl(10unit)を添加し、37℃で
1時間放置した。 次に、1M-Tris-HCl(PH7.5) 8μl、
alkalinephosphatase 2μlを添加し、37℃で1時間放置
した。その後15,000rpmで3分遠沈を行い、上清をHPLCの
試料とした。
(3) Extraction of DNA from cells The DNA in the recovered cells was used as DNAExtr from Wako Pure Chemical Industries, Ltd.
Extracted by actor WB kit. 75 μl of distilled water was added to the extract, and the mixture was left at 4 ° C. for one day. After that, the solution was heated at 95 ° C for 5 minutes and then rapidly cooled, and 2M-sodium acetate buffer (PH4.
5) 1 μl and nuclease P 1 5 μl (10 units) were added and left at 37 ° C. for 1 hour. Next, 8 μl of 1M-Tris-HCl (PH7.5),
2 μl of alkaline phosphatase was added and left at 37 ° C. for 1 hour. After that, centrifugation was performed at 15,000 rpm for 3 minutes, and the supernatant was used as a sample for HPLC.

【0035】(4)HPLCによる8-OHdGおよび2-デオキシ
グアノシンの検出移動相はメタノール80mlと0.2Mリン酸
二水素ナトリウム50mlを加え、蒸留水で1Lにしたもの
を用いた。カラムはDAISOPAK(SP-120-5-ODS-BP)150mm×
6mmを用い、8-OHdGの検出はESD検出器により下記の条件
で行った。また、2-デオキシグアノシンの検出は290nm
のUV検出器にて行った。
(4) Detection of 8-OHdG and 2-deoxyguanosine by HPLC A mobile phase was prepared by adding 80 ml of methanol and 50 ml of 0.2M sodium dihydrogen phosphate and adjusting the volume to 1 L with distilled water. Column is DAISOPAK (SP-120-5-ODS-BP) 150 mm ×
Using 6 mm, 8-OHdG was detected by an ESD detector under the following conditions. In addition, the detection of 2-deoxyguanosine is 290 nm
UV detector.

【0036】ECD検出条件 GUARD CELL INSTALLED E:350mV CH 1:E150mV,R100μA,FILTER 2 SEC,OUTPUT  1 V,OFFSET 0% CH 2:E300mV,R 50nA,FILTER 10 SEC,OUTPUT 100mV,OFFSET 0%ECD detection conditions GUARD CELL INSTALLED E: 350mV CH 1: E150mV, R100μA, FILTER 2 SEC, OUTPUT   1 V, OFFSET 0% CH 2: E300mV, R 50nA, FILTER 10 SEC, OUTPUT 100mV, OFFSET 0%

【0037】[0037]

【表1】に各種成分の紫外線による8-OHdGの産生抑制結
果を示す。8-OHdGの産生率(%)は以下の計算で求め
た。
[Table 1] shows the results of suppressing the production of 8-OHdG by ultraviolet rays of various components. The production rate (%) of 8-OHdG was calculated by the following calculation.

【0038】[0038]

【化1】 [Chemical 1]

【0039】[0039]

【表1】に示したようにエピカテキン、エピガロカテキ
ンガレート、フラボン、ミリセチン、ケンフェロール、
ナリンゲニン、ナリンギン、ゲニステイン、ゲニスチ
ン、エスクレチン、およびブドウ、オオバコ、エゾオオ
バコ、亜麻、紅花、綿花の種子、ローズマリー、グア
バ、ユーカリ、エバーラスティング、ワイルドタイム、
イブキジャコウソウ、ライラック、さらにフランス海岸
松の樹皮の抽出物はいずれも高い8-OHdG 産生抑制効果
を示した。
As shown in [Table 1], epicatechin, epigallocatechin gallate, flavone, myricetin, kaempferol,
Naringenin, naringin, genistein, genistin, esculetin, and grape, psyllium, psyllium, flax, safflower, cotton seed, rosemary, guava, eucalyptus, everlasting, wild time,
The extract of bark of Pleurotus cornucopiae, Lilac and French pine pine all showed a high inhibitory effect on 8-OHdG production.

【0040】[0040]

【表1】 [Table 1]

【0041】次に本発明の各種成分を配合した化粧料の
処方例の例を示すが本発明はこれに限定されるものでな
い。 化粧料の処方例
Next, examples of formulation of cosmetics containing various components of the present invention will be shown, but the present invention is not limited thereto. Cosmetic prescription example

【0042】(1)化粧用クリーム(重量%) a)ミツロウ…2.0 b)ステアリルアルコール…5.0 c)ステアリン酸…8.0 d)スクワラン…10.0 e)自己乳化型グリセリルモノステアレート…3.0 f)ポリオキシエチレンセチルエーテル(20E.O.)…1.0 g)ブドウ(葉)水溶液抽出物…3.0 h)ケンフェロール…0.5 i)1,3-ブチレングリコール…5.0 j)水酸化カリウム…0.3 k)防腐剤・酸化防止剤…適量 l)精製水…残部 製法a)〜f)までを加熱溶解し、80℃に保つ。g)〜l)まで
を加熱溶解し、80℃に保ち、a)〜f)に加えて乳化し、40
℃まで撹拌しながら冷却する。
(1) Cosmetic cream (% by weight) a) Beeswax ... 2.0 b) Stearyl alcohol ... 5.0 c) Stearic acid ... 8.0 d) Squalane ... 10.0 e) Self-emulsifying glyceryl monostearate ... 3.0 f) Polyoxy Ethylene cetyl ether (20 E.O.)… 1.0 g) Grape (leaf) aqueous extract… 3.0 h) Kaempferol… 0.5 i) 1,3-butylene glycol… 5.0 j) Potassium hydroxide… 0.3 k) Preservatives Antioxidant: Appropriate amount l) Purified water: Remaining manufacturing method a) to f) are dissolved by heating and kept at 80 ° C. g) to l) are heated and dissolved, kept at 80 ° C, added to a) to f) and emulsified to 40
Cool to 0 ° C with stirring.

【0043】(1)化粧用クリーム(重量%) a)ミツロウ…2.0 b)ステアリルアルコール…5.0 c)ステアリン酸…8.0 d)スクワラン…10.0 e)自己乳化型グリセリルモノステアレート…3.0 f)ポリオキシエチレンセチルエーテル(20E.O.)…1.0 g)ケンフェロール…0.5 h)1,3-ブチレングリコール…5.0 i)水酸化カリウム…0.3 j)防腐剤・酸化防止剤…適量 k)精製水…残部 製法a)〜g)までを加熱溶解し、80℃に保つ。h)〜k)ま
でを加熱溶解し、80℃に保ち、a)〜g)に加えて乳化し、
40℃まで撹拌しながら冷却する。
(1) Cosmetic cream (% by weight) a) Beeswax ... 2.0 b) Stearyl alcohol ... 5.0 c) Stearic acid ... 8.0 d) Squalane ... 10.0 e) Self-emulsifying glyceryl monostearate ... 3.0 f) Polyoxy Ethylene cetyl ether (20E.O.)… 1.0 g) Kaempferol… 0.5 h) 1,3-butylene glycol… 5.0 i) Potassium hydroxide… 0.3 j) Preservatives / antioxidants… Appropriate amount k) Purified water… The balance Processes a) to g) are dissolved by heating and kept at 80 ° C. h) to k) are melted by heating, kept at 80 ° C., added to a) to g) and emulsified,
Cool to 40 ° C with stirring.

【0044】(2)乳液(重量%) a)ミツロウ…0.5 b)ワセリン…2.0 c)スクワラン…8.0 d)ソルビタンセスキオレエート…0.8 e)ポリオキシエチレンオレイルエーテル(20E.O.)…1.2 f)エピガロカテキンガレート…0.5 g)グアバ(葉)50%1,3-フ゛チレンク゛リコール水溶液抽出物…2.0 h)1,3-ブチレングリコール…7.0 i)カルボキシビニルポリマー…0.2 j)水酸化カリウム…0.1 k)精製水…残部 l)防腐剤・酸化防止剤…適量 m)エタノール…7.0 製法a)〜e)までを加熱溶解し、80℃に保つ。f)〜l)まで
を加熱溶解し、80℃に保ち、a)〜e)に加えて乳化し、50
℃まで撹拌しながら冷却する。50℃でm)を添加し、40℃
まで冷却する。
(2) Emulsion (% by weight) a) Beeswax ... 0.5 b) Vaseline ... 2.0 c) Squalane ... 8.0 d) Sorbitan sesquioleate ... 0.8 e) Polyoxyethylene oleyl ether (20 E.O.) ... 1.2 f ) Epigallocatechin gallate ... 0.5 g) Guava (leaf) 50% 1,3-butylene glycol aqueous solution extract ... 2.0 h) 1,3-butylene glycol ... 7.0 i) Carboxyvinyl polymer ... 0.2 j) Potassium hydroxide ... 0.1 k) Purified water: the rest l) Preservative / antioxidant ... Appropriate amount m) Ethanol: 7.0 Dissolve by heating process a) to e) and keep at 80 ° C. f) to l) are melted by heating, kept at 80 ° C, added to a) to e) and emulsified to 50
Cool to 0 ° C with stirring. M) at 50 ℃, add 40 ℃
Cool down.

【0045】(2)乳液(重量%) a)ミツロウ…0.5 b)ワセリン…2.0 c)スクワラン…8.0 d)ソルビタンセスキオレエート…0.8 e)ポリオキシエチレンオレイルエーテル(20E.O.)…1.2 f)フランス海岸松(根)水溶液抽出物…2.0 g)1,3-ブチレングリコール…7.0 h)カルボキシビニルポリマー…0.2 i)水酸化カリウム…0.1 j)精製水…残部 k)防腐剤・酸化防止剤…適量 l)エタノール…7.0 製法a)〜e)までを加熱溶解し、80℃に保つ。f)〜k)まで
を加熱溶解し、80℃に保ち、a)〜e)に加えて乳化し、50
℃まで撹拌しながら冷却する。50℃でl)を添加し、40℃
まで冷却する。
(2) Emulsion (% by weight) a) Beeswax ... 0.5 b) Vaseline ... 2.0 c) Squalane ... 8.0 d) Sorbitan sesquioleate ... 0.8 e) Polyoxyethylene oleyl ether (20 E.O.) ... 1.2 f ) French coastal pine (root) aqueous solution extract… 2.0 g) 1,3-butylene glycol… 7.0 h) Carboxyvinyl polymer… 0.2 i) Potassium hydroxide… 0.1 j) Purified water… balance k) Preservatives / antioxidants … Appropriate amount l) Ethanol… 7.0 Dissolve by heating process a) to e) and keep at 80 ℃. f) to k) are melted by heating, kept at 80 ° C, added to a) to e) and emulsified.
Cool to 0 ° C with stirring. L) at 50 ℃, add 40 ℃
Cool down.

【0046】(3)化粧水(重量%) a)エバーラスティング(全草)50%ク゛リセリン水溶液抽出物
…1.0 b)ワイルドタイム(花)20%フ゜ロヒ゜レンク゛リコール水溶液抽出物
…1.0 c)グリセリン…5.0 d)ポリオキシエチレンソルビタンモノラウレート(20E.
O.)…1.0 e)エタノール…6.0 f)香料…適量 g)防腐剤・酸化防止剤…適量 h)精製水…残部 製法a)〜h)までを混合し、均一に溶解する。
(3) Lotion (% by weight) a) Everlasting (whole grass) 50% glycerin aqueous solution extract 1.0 b) Wild thyme (flower) 20% propylene glycol aqueous solution extract 1.0 c) Glycerin 5.0 d) Polyoxyethylene sorbitan monolaurate (20E.
O.)… 1.0 e) Ethanol… 6.0 f) Perfume… Appropriate amount g) Preservative / antioxidant… Appropriate amount h) Purified water… The rest of the manufacturing methods a) to h) are mixed and uniformly dissolved.

【0047】(3)化粧水(重量%) a)ライラック(根)20%酢酸エチル水溶液抽出物…1.0 b)グリセリン…5.0 c)ポリオキシエチレンソルビタンモノラウレート(20E.
O.)…1.0 d)エタノール…6.0 e)香料…適量 f)防腐剤・酸化防止剤…適量 g)精製水…残部 製法a)〜g)までを混合し、均一に溶解する。
(3) Lotion (% by weight) a) Lilac (root) 20% ethyl acetate aqueous solution extract ... 1.0 b) Glycerin ... 5.0 c) Polyoxyethylene sorbitan monolaurate (20E.
O.) ... 1.0 d) Ethanol ... 6.0 e) Perfume ... Appropriate amount f) Preservative / antioxidant ... Appropriate amount g) Purified water ... Remaining manufacturing method a) to g) are mixed and uniformly dissolved.

【0048】(4)パック剤(重量%) a)ミリセチン…1.0 b)ローズマリー(茎)20%エタノール水溶液抽出物…2.0 c)酢酸ビニル樹脂エマルジョン…15.0 d)ポリビニルアルコール…10.0 e)オリーブ油…3.0 f)グリセリン…5.0 g)酸化チタン…8.0 h)カオリン…7.0 i)エタノール…8.0 j)香料…適量 k)防腐剤・酸化防止剤…適量 l)精製水…残部 製法a)〜l)までを混合し、よく撹拌、分散させ均一にす
る。
(4) Packing agent (% by weight) a) Myricetin ... 1.0 b) Rosemary (stem) 20% ethanol aqueous solution extract ... 2.0 c) Vinyl acetate resin emulsion ... 15.0 d) Polyvinyl alcohol ... 10.0 e) Olive oil ... 3.0 f) Glycerin… 5.0 g) Titanium oxide… 8.0 h) Kaolin… 7.0 i) Ethanol… 8.0 j) Perfume… Appropriate amount k) Preservatives / antioxidants… Appropriate amount l) Purified water… Remaining process a) to l) Are mixed and well stirred and dispersed to homogenize.

【0049】(4)パック剤(重量%) a)ミリセチン…1.0 b)エタノール…8.0 c)酢酸ビニル樹脂エマルジョン…15.0 d)ポリビニルアルコール…10.0 e)オリーブ油…3.0 f)グリセリン…5.0 g)酸化チタン…8.0 h)カオリン…7.0 i)香料…適量 j)防腐剤・酸化防止剤…適量 k)精製水…残部 製法a)〜k)までを混合し、よく撹拌、分散させ均一にす
る。
(4) Packing agent (% by weight) a) Myricetin ... 1.0 b) Ethanol ... 8.0 c) Vinyl acetate resin emulsion ... 15.0 d) Polyvinyl alcohol ... 10.0 e) Olive oil ... 3.0 f) Glycerin ... 5.0 g) Titanium oxide … 8.0 h) Kaolin… 7.0 i) Perfume… Appropriate amount j) Preservative / antioxidant… Appropriate amount k) Purified water… The rest of the processes a) to k) are mixed, and well stirred and dispersed to homogenize.

【0050】[0050]

【効果確認試験】(1)塗布によるヒトでの効果確認試
験 被験者として、20〜50歳の女性15名に1日2回
(朝、夜)連続2ヵ月間、本発明品と比較品のそれぞれ
を使用させ、塗布部位の状態を試験前後で比較し、改善
効果を調べた。本試験には、
[Effect confirmation test] (1) Effect confirmation test on humans by application As test subjects, 15 women aged 20 to 50 years twice a day (morning, night) for 2 consecutive months, each of the invention product and the comparative product The state of the application site was compared before and after the test, and the improvement effect was investigated. For this test,

【0042】で示した化粧料を用い、比較例にはUsing the cosmetics shown in, the comparative example

【0042】に示した化粧料からブドウ(葉)抽出物、
ケンフェロールを除いた化粧料を作成し、その塗布によ
る効果について調べた。本発明の有効成分を配合した化
粧料を毎日塗布しながら肌の色素沈着状態およびシワの
状態を塗布開始前及び2ヶ月塗布後におけるアンケート
で集計し、効果の確認を行った。結果は
Grape (leaf) extract from the cosmetics shown in
A cosmetic excluding kaempferol was prepared and the effect of its application was investigated. While applying the cosmetic containing the active ingredient of the present invention every day, the pigmentation state and wrinkle state of the skin were summarized by questionnaires before the start of application and after 2 months of application to confirm the effect. Result is

【表2】に示す。[Table 2] shows.

【0051】[0051]

【判定基準】[Judgment criteria]

著効:塗布開始前と比較して皮膚のシミ・シワが著しく
改善した。 有効:塗布開始前と比較して皮膚のシミ・シワが改善し
た。 やや有効:塗布開始前と比較して皮膚のシミ・シワが少
し改善した。 無効:塗布開始前と比較して変化がなかった。
Marked effect: Skin spots and wrinkles were remarkably improved as compared with those before the start of application. Effective: Skin stains and wrinkles were improved compared to before application. Slightly effective: Skin stains / wrinkles were slightly improved compared to before application. Ineffective: There was no change compared to before application.

【0052】[0052]

【表2】 [Table 2]

【0053】[0053]

【表2】からも明らかなように、対照品と比較していず
れも高い効果が認められた。
As is clear from [Table 2], higher effects were observed in all cases as compared with the control product.

【0054】[0054]

【発明の効果】以上詳述したごとく、本発明の化粧料
は、8-OHdG産生抑制効果に優れており、皮膚のシミ・シ
ワの防止に有効である。
As described in detail above, the cosmetic of the present invention has an excellent effect of suppressing 8-OHdG production, and is effective in preventing spots and wrinkles on the skin.

フロントページの続き Fターム(参考) 4C083 AA082 AA111 AA112 AB032 AB052 AB242 AB442 AC012 AC022 AC072 AC102 AC122 AC182 AC242 AC422 AC442 AC841 AC842 AD092 AD112 BB51 CC04 CC05 CC07 DD23 DD31 EE01 EE06 EE07 EE10 EE16 EE17 Continued front page    F-term (reference) 4C083 AA082 AA111 AA112 AB032                       AB052 AB242 AB442 AC012                       AC022 AC072 AC102 AC122                       AC182 AC242 AC422 AC442                       AC841 AC842 AD092 AD112                       BB51 CC04 CC05 CC07 DD23                       DD31 EE01 EE06 EE07 EE10                       EE16 EE17

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】カテキン類および/又はその配糖体、フラ
ボン類および/又はその配糖体、フラボノール類および
/又はその配糖体、フラバノン類および/又はその配糖
体、イソフラボン類および/又はその配糖体、クマリン
類および/又はその配糖体の1種又は2種以上からなる8-
OHdG(8-ハイドロキシデオキシグアノシン)産生抑制剤
を配合することを特徴とする化粧料。
1. Catechins and / or glycosides thereof, flavones and / or glycosides thereof, flavonols and / or glycosides thereof, flavanones and / or glycosides thereof, isoflavones and / or A glycoside, coumarin and / or one or more glycosides 8-
A cosmetic comprising an OHdG (8-hydroxydeoxyguanosine) production inhibitor.
【請求項2】ビチス(Vitis)属、プランタゴ(Plantag
o)属、リナム(Linum)属、カーサマス(Carthamus)
属、ゴシピウム(Gossypium)属、ローズマリー(Rosma
rinus)属、バンザクロ(Psidium)属、ユーカリ(Euca
lyptus)属、グナファリウム(Gnaphalium)属、サイム
ス(Thymus)属、シリンガ(Syringa)属、マツ(Pinu
s)属に属する植物の抽出物の1種又は2種以上からなる8
-OHdG(8-ハイドロキシデオキシグアノシン)産生抑制
剤を配合することを特徴とする化粧料。
2. A genus of Vitis, Plantag
o) Genus, Linum genus, Carthamus
Genus, Gossypium, Rosemary
rinus), Pomedium (Psidium), Eucalyptus (Euca)
lyptus genus, Gnaphalium genus, Thymus genus, Syringa genus, Pinus (Pinu)
s) 1 or 2 or more extracts of plants belonging to the genus 8
A cosmetic composition comprising a -OHdG (8-hydroxydeoxyguanosine) production inhibitor.
【請求項3】カテキン類および/又はその配糖体がカテ
キン、エピカテキン、エピガロカテキン、エピガロカテ
キンガレート、フラボン類がルテオリン、フラボン、ア
ピゲニンおよび/又はその配糖体、フラボノール類がク
エルセチン、ミリセチン、ケンフェロールおよび/又は
その配糖体、フラバノン類がナリンゲニン、フラバノ
ン、ヘスペリジンおよび/又はその配糖体、イソフラボ
ン類がゲニステイン、ダイゼインおよび/又はその配糖
体、クマリン類がエスクレチンおよび/又はその配糖体
である請求項1記載の化粧料。
3. Catechins and / or glycosides thereof are catechin, epicatechin, epigallocatechin, epigallocatechin gallate, flavones are luteolin, flavones, apigenin and / or glycosides thereof, and flavonols are quercetin, Myricetin, kaempferol and / or its glycosides, flavanones are naringenin, flavanones, hesperidin and / or its glycosides, isoflavones are genistein, daidzein and / or their glycosides, coumarins are esculetins and / or their The cosmetic according to claim 1, which is a glycoside.
【請求項4】ビチス(Vitis)属植物がブドウ(Vitis v
inifera L.)、プランタゴ(Plantago)属植物がオオバ
コ(Plantagomajor L. var. asiatica QECAISNE)、エ
ゾオオバコ(Plantago camtschaticaCham. Ex Lin
k)、リナム(Linum)属植物が亜麻(Linumusitatissim
um L.)、カーサマス(Carthamus)属植物が紅花(Cart
hamus tinctorius L.)、ゴシピウム(Gossypium)属植
物が綿花(Gossypiumherbaceum LINNAEUS)、ローズマ
リー(Rosmarinus)属に属する植物がローズマリー(Ro
smarinusofficinalis L.)、バンザクロ(Psidium)属
に属する植物がグアバ(Psidium guajava L.)、ユーカ
リ(Eucalyptus)属に属する植物がユーカリ(Eucalypt
usglobules LABILL.)、グナファリウム(Gnaphalium)
属に属する植物がエバーラスティング(Gnaphaliumulig
inosum L.)、サイムス(Thymus)属に属する植物がワ
イルドタイム(Thymus serpyllum L.)、イブキジャコ
ウソウ(Thymus quinquecostatus Celak.)、シリン
ガ(Syringa)属に属する植物がライラック(Syringavu
lgaris)、マツ(Pinus)属に属する植物がフランス海
岸松(Pinus pinaster)である植物抽出物の1種又は2
種以上からなる請求項2記載の化粧料。
4. A plant of the genus Vitis is grape (Vitis v).
inifera L.), Plantago genus plants are plantain (Plantagomajor L. var. asiatica Q ECAISNE ), Ezo plantain (Plantago camtschaticaCham. Ex Lin
k), Linum plants are flax (Linumusitatissim)
um L.), Carthamus plant is safflower (Cart
hamus tinctorius L.), Gossypium plants are cotton (Gossypium herbaceum L INNAEUS ), and rosemary (Rosmarinus) plants are rosemary (Ro
smarinusofficinalis L.), plants belonging to the genus Psidium are guava (Psidium guajava L.), and plants belonging to the genus Eucalyptus are eucalyptus (Eucalypt).
usglobules L ABILL .), Gnaphalium
Plants belonging to the genus Everlasting (Gnaphaliumulig
inosum L.), plants belonging to the genus Thymus are wild thyme (Thymus serpyllum L.), plants belonging to the genus Thymus quinquecostatus Celak., and syringa (Syringa).
lgaris), one or two plant extracts whose plants belonging to the genus Pinus are French coastal pines (Pinus pinaster)
The cosmetic composition according to claim 2, comprising at least one kind.
JP2001189617A 2001-06-22 2001-06-22 8-OHdG (8-hydroxydeoxyguanosine) production inhibitor Expired - Lifetime JP4901024B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001189617A JP4901024B2 (en) 2001-06-22 2001-06-22 8-OHdG (8-hydroxydeoxyguanosine) production inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001189617A JP4901024B2 (en) 2001-06-22 2001-06-22 8-OHdG (8-hydroxydeoxyguanosine) production inhibitor

Publications (2)

Publication Number Publication Date
JP2003002819A true JP2003002819A (en) 2003-01-08
JP4901024B2 JP4901024B2 (en) 2012-03-21

Family

ID=19028511

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001189617A Expired - Lifetime JP4901024B2 (en) 2001-06-22 2001-06-22 8-OHdG (8-hydroxydeoxyguanosine) production inhibitor

Country Status (1)

Country Link
JP (1) JP4901024B2 (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003238425A (en) * 2002-02-18 2003-08-27 Toyo Shinyaku:Kk Thyrosinase inhibitor and skin external agent
JP2005112760A (en) * 2003-10-07 2005-04-28 Ichimaru Pharcos Co Ltd Bleaching ingredient and external preparation for skin for bleaching
JP2005206466A (en) * 2004-01-20 2005-08-04 Naris Cosmetics Co Ltd Wrinkle-smoothing skin lotion
JP2005343864A (en) * 2004-06-07 2005-12-15 Kuraray Co Ltd Skin care preparation for external use
JP2006199610A (en) * 2005-01-19 2006-08-03 Kao Corp Wrinkle-improving agent
JP2007161681A (en) * 2005-12-16 2007-06-28 Mitsui Chemicals Inc Agent for preventing wrinkle and improving skin condition
JP2007217479A (en) * 2006-02-15 2007-08-30 Toyo Shinyaku:Kk Barley young leaf soap
JP2009079016A (en) * 2007-09-27 2009-04-16 Hajime Kozano Raw material for cosmetic and cosmetic
JP2009234976A (en) * 2008-03-27 2009-10-15 Kose Corp Cell activator and external preparation for skin for antiaging
JP2011006462A (en) * 2010-08-26 2011-01-13 Ichimaru Pharcos Co Ltd Tyrosinase activity inhibitor
JP2011051967A (en) * 2009-08-03 2011-03-17 Fancl Corp Contracting agent for collagen gel
JP2011102272A (en) * 2009-11-11 2011-05-26 Shiseido Co Ltd Tie2-activating agent, agent for maturing, normalizing or stabilizing blood vessel, lymphatic vessel-stabilizing agent, and wrinkle-preventing/ameliorating agent and dropsy-ameliorating/preventing agent
JP2012062278A (en) * 2010-09-16 2012-03-29 Fancl Corp Cosmetic beverage containing apple extract and collagen tripeptide
WO2012101746A1 (en) * 2011-01-24 2012-08-02 株式会社資生堂 Tie-2 activator, agent for maturation, normalization, or stabilization of blood vessels, lymph vessel stabilizing agent, wrinkle prevention/improvement agent, and edema improvement/prevention agent
US20140004210A1 (en) * 2012-06-28 2014-01-02 Shiseido Company, Ltd. Degradation inhibitor of hyaluronic acid, comprising rosemary extract and retinol acetate
JP2014530906A (en) * 2011-10-27 2014-11-20 株式会社アモーレパシフィックAmorepacific Corporation Skin improvement composition containing syringaresinol
CN113546014A (en) * 2021-07-26 2021-10-26 广州市百益康生物科技发展有限公司 Method for extracting dissolved tea polyphenol and Perilla oil and skin moistening oil thereof
WO2022224619A1 (en) * 2021-04-23 2022-10-27 一丸ファルコス株式会社 Collagen production enhancer and topical skin agent including same
CN117815216A (en) * 2019-04-19 2024-04-05 株式会社资生堂 Anti-photoaging and/or dermis pigmentation inhibitor

Citations (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55111411A (en) * 1979-02-19 1980-08-28 Sansho Seiyaku Kk Cosmetic for making fair skin
JPS5735506A (en) * 1980-08-11 1982-02-26 Sansho Seiyaku Kk Bleaching cosmetic
JPS59216810A (en) * 1983-05-24 1984-12-06 Osaka Chem Lab Cosmetic composition containing catechin compound
JPS63208506A (en) * 1987-02-24 1988-08-30 Nonogawa Shoji:Kk Cosmetic
JPH0393782A (en) * 1989-08-30 1991-04-18 Pacific Chem Ind Co Cell protective agent for protecting cell from activated oxygens and method of its preparation
JPH05229956A (en) * 1992-02-24 1993-09-07 Mikimoto Pharmaceut Co Ltd Antioxidant
JPH05246837A (en) * 1992-03-09 1993-09-24 Mikimoto Pharmaceut Co Ltd Cosmetic
JPH0616531A (en) * 1992-07-02 1994-01-25 Nonogawa Shoji Kk Cosmetic
JPH0688063A (en) * 1992-09-04 1994-03-29 Natl Food Res Inst Ultraviolet protective
JPH06305978A (en) * 1993-04-21 1994-11-01 Maruzen Pharmaceut Co Ltd Tyrosinase inhibitor, beautifying cosmetic and color change preventing agent
JPH06321752A (en) * 1993-05-07 1994-11-22 Kao Corp Skin beautifying agent
JPH07157494A (en) * 1993-12-06 1995-06-20 Kao Corp New isoflavone glycoside and cosmetic containing the same
JPH07309739A (en) * 1994-05-20 1995-11-28 Narisu Keshohin:Kk Suppressant for fragmentation of mucopolysaccharides and cosmetic
JPH07324025A (en) * 1994-05-31 1995-12-12 Sankoudou:Kk External agent for suppressing maillard reaction
JPH10175859A (en) * 1996-10-18 1998-06-30 Dokutaazu Kosumeteikusu:Kk External preparation for skin for improving water (of chinese medicine idea)
JPH10291929A (en) * 1997-04-21 1998-11-04 Nagase & Co Ltd Wrinkle suppressive preparation for external use for skin
WO1998056373A1 (en) * 1997-06-11 1998-12-17 Gorbach Sherwood L Isoflavonoids for treatment and prevention of aging skin and wrinkles
JPH1121226A (en) * 1997-07-02 1999-01-26 Shiyuu Uemura Keshohin:Kk Skin preparation for external use for suppressing melanin production
JPH1179971A (en) * 1997-09-03 1999-03-23 Shiseido Co Ltd Anti-aging agent
JPH11246337A (en) * 1998-03-03 1999-09-14 Shiseido Co Ltd Antiaging agent
WO1999047118A1 (en) * 1998-03-16 1999-09-23 The Procter & Gamble Company Compositions for regulating skin appearance
JPH11349436A (en) * 1998-06-03 1999-12-21 Noevir Co Ltd Collagenase inhibitor and skin agent containing the same and used for external use
JP2000026306A (en) * 1998-07-14 2000-01-25 Kikkoman Corp Hyaluronidase inhibitor
JP2000229834A (en) * 1999-02-10 2000-08-22 Kanebo Ltd Cosmetic
JP2000511907A (en) * 1996-06-07 2000-09-12 マウント シナイ スクール オブ メディシン オブ ザ シティ オブ ニューヨーク Genistein as a prophylactic against UV-induced skin photodamage and cancer
JP2000319154A (en) * 1999-05-06 2000-11-21 Nippon Menaade Keshohin Kk Phototoxicity inhibitor
JP2001048773A (en) * 1999-08-10 2001-02-20 Naris Cosmetics Co Ltd Cosmetic
JP2001081008A (en) * 1999-07-15 2001-03-27 Shiseido Co Ltd Skin preparation for external use keeping and improving the skin from chapping
JP2001097844A (en) * 1999-09-29 2001-04-10 Pola Chem Ind Inc Anti-aging agent and cosmetic containing the same and used for preventing aging
JP2001114636A (en) * 1999-10-14 2001-04-24 Noevir Co Ltd Hyaluronic acid production and catalase production promoting agent, fibroblast activating agent and skin lotion
JP2001122733A (en) * 1999-10-26 2001-05-08 Noevir Co Ltd Catalase production-promoting preparation and skin preparation for external use containing the same
JP2001288032A (en) * 2000-04-07 2001-10-16 Kanebo Ltd Active oxygen-eliminating agent and skin cosmetic for preventing aging
JP2002145731A (en) * 2000-11-10 2002-05-22 Katakura Chikkarin Co Ltd Cosmetic
JP2003002813A (en) * 2001-11-07 2003-01-08 Naris Cosmetics Co Ltd Skin care composition
JP2003002820A (en) * 2001-06-22 2003-01-08 Naris Cosmetics Co Ltd Skin care composition
JP2003002811A (en) * 2001-11-07 2003-01-08 Naris Cosmetics Co Ltd IgE PRODUCTION INHIBITOR

Patent Citations (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55111411A (en) * 1979-02-19 1980-08-28 Sansho Seiyaku Kk Cosmetic for making fair skin
JPS5735506A (en) * 1980-08-11 1982-02-26 Sansho Seiyaku Kk Bleaching cosmetic
JPS59216810A (en) * 1983-05-24 1984-12-06 Osaka Chem Lab Cosmetic composition containing catechin compound
JPS63208506A (en) * 1987-02-24 1988-08-30 Nonogawa Shoji:Kk Cosmetic
JPH0393782A (en) * 1989-08-30 1991-04-18 Pacific Chem Ind Co Cell protective agent for protecting cell from activated oxygens and method of its preparation
JPH05229956A (en) * 1992-02-24 1993-09-07 Mikimoto Pharmaceut Co Ltd Antioxidant
JPH05246837A (en) * 1992-03-09 1993-09-24 Mikimoto Pharmaceut Co Ltd Cosmetic
JPH0616531A (en) * 1992-07-02 1994-01-25 Nonogawa Shoji Kk Cosmetic
JPH0688063A (en) * 1992-09-04 1994-03-29 Natl Food Res Inst Ultraviolet protective
JPH06305978A (en) * 1993-04-21 1994-11-01 Maruzen Pharmaceut Co Ltd Tyrosinase inhibitor, beautifying cosmetic and color change preventing agent
JPH06321752A (en) * 1993-05-07 1994-11-22 Kao Corp Skin beautifying agent
JPH07157494A (en) * 1993-12-06 1995-06-20 Kao Corp New isoflavone glycoside and cosmetic containing the same
JPH07309739A (en) * 1994-05-20 1995-11-28 Narisu Keshohin:Kk Suppressant for fragmentation of mucopolysaccharides and cosmetic
JPH07324025A (en) * 1994-05-31 1995-12-12 Sankoudou:Kk External agent for suppressing maillard reaction
JP2000511907A (en) * 1996-06-07 2000-09-12 マウント シナイ スクール オブ メディシン オブ ザ シティ オブ ニューヨーク Genistein as a prophylactic against UV-induced skin photodamage and cancer
JPH10175859A (en) * 1996-10-18 1998-06-30 Dokutaazu Kosumeteikusu:Kk External preparation for skin for improving water (of chinese medicine idea)
JPH10291929A (en) * 1997-04-21 1998-11-04 Nagase & Co Ltd Wrinkle suppressive preparation for external use for skin
WO1998056373A1 (en) * 1997-06-11 1998-12-17 Gorbach Sherwood L Isoflavonoids for treatment and prevention of aging skin and wrinkles
JP2002511860A (en) * 1997-06-11 2002-04-16 シャーウッド エル. ゴルバッハ Isoflavonoids for treating and preventing skin aging and wrinkles
JPH1121226A (en) * 1997-07-02 1999-01-26 Shiyuu Uemura Keshohin:Kk Skin preparation for external use for suppressing melanin production
JPH1179971A (en) * 1997-09-03 1999-03-23 Shiseido Co Ltd Anti-aging agent
JPH11246337A (en) * 1998-03-03 1999-09-14 Shiseido Co Ltd Antiaging agent
WO1999047118A1 (en) * 1998-03-16 1999-09-23 The Procter & Gamble Company Compositions for regulating skin appearance
JP2002506807A (en) * 1998-03-16 2002-03-05 ザ、プロクター、エンド、ギャンブル、カンパニー How to adjust skin appearance
WO1999047119A1 (en) * 1998-03-16 1999-09-23 The Procter & Gamble Company Methods for regulating skin appearance
JP2002506806A (en) * 1998-03-16 2002-03-05 ザ、プロクター、エンド、ギャンブル、カンパニー Composition for regulating skin appearance
JPH11349436A (en) * 1998-06-03 1999-12-21 Noevir Co Ltd Collagenase inhibitor and skin agent containing the same and used for external use
JP2000026306A (en) * 1998-07-14 2000-01-25 Kikkoman Corp Hyaluronidase inhibitor
JP2000229834A (en) * 1999-02-10 2000-08-22 Kanebo Ltd Cosmetic
JP2000319154A (en) * 1999-05-06 2000-11-21 Nippon Menaade Keshohin Kk Phototoxicity inhibitor
JP2001081008A (en) * 1999-07-15 2001-03-27 Shiseido Co Ltd Skin preparation for external use keeping and improving the skin from chapping
JP2001048773A (en) * 1999-08-10 2001-02-20 Naris Cosmetics Co Ltd Cosmetic
JP2001097844A (en) * 1999-09-29 2001-04-10 Pola Chem Ind Inc Anti-aging agent and cosmetic containing the same and used for preventing aging
JP2001114636A (en) * 1999-10-14 2001-04-24 Noevir Co Ltd Hyaluronic acid production and catalase production promoting agent, fibroblast activating agent and skin lotion
JP2001122733A (en) * 1999-10-26 2001-05-08 Noevir Co Ltd Catalase production-promoting preparation and skin preparation for external use containing the same
JP2001288032A (en) * 2000-04-07 2001-10-16 Kanebo Ltd Active oxygen-eliminating agent and skin cosmetic for preventing aging
JP2002145731A (en) * 2000-11-10 2002-05-22 Katakura Chikkarin Co Ltd Cosmetic
JP2003002820A (en) * 2001-06-22 2003-01-08 Naris Cosmetics Co Ltd Skin care composition
JP2003002813A (en) * 2001-11-07 2003-01-08 Naris Cosmetics Co Ltd Skin care composition
JP2003002811A (en) * 2001-11-07 2003-01-08 Naris Cosmetics Co Ltd IgE PRODUCTION INHIBITOR

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003238425A (en) * 2002-02-18 2003-08-27 Toyo Shinyaku:Kk Thyrosinase inhibitor and skin external agent
JP2005112760A (en) * 2003-10-07 2005-04-28 Ichimaru Pharcos Co Ltd Bleaching ingredient and external preparation for skin for bleaching
JP2005206466A (en) * 2004-01-20 2005-08-04 Naris Cosmetics Co Ltd Wrinkle-smoothing skin lotion
JP2005343864A (en) * 2004-06-07 2005-12-15 Kuraray Co Ltd Skin care preparation for external use
JP2006199610A (en) * 2005-01-19 2006-08-03 Kao Corp Wrinkle-improving agent
JP2007161681A (en) * 2005-12-16 2007-06-28 Mitsui Chemicals Inc Agent for preventing wrinkle and improving skin condition
JP2007217479A (en) * 2006-02-15 2007-08-30 Toyo Shinyaku:Kk Barley young leaf soap
JP2009079016A (en) * 2007-09-27 2009-04-16 Hajime Kozano Raw material for cosmetic and cosmetic
JP2009234976A (en) * 2008-03-27 2009-10-15 Kose Corp Cell activator and external preparation for skin for antiaging
JP2011051967A (en) * 2009-08-03 2011-03-17 Fancl Corp Contracting agent for collagen gel
JP2011102272A (en) * 2009-11-11 2011-05-26 Shiseido Co Ltd Tie2-activating agent, agent for maturing, normalizing or stabilizing blood vessel, lymphatic vessel-stabilizing agent, and wrinkle-preventing/ameliorating agent and dropsy-ameliorating/preventing agent
JP2011006462A (en) * 2010-08-26 2011-01-13 Ichimaru Pharcos Co Ltd Tyrosinase activity inhibitor
JP2012062278A (en) * 2010-09-16 2012-03-29 Fancl Corp Cosmetic beverage containing apple extract and collagen tripeptide
WO2012101746A1 (en) * 2011-01-24 2012-08-02 株式会社資生堂 Tie-2 activator, agent for maturation, normalization, or stabilization of blood vessels, lymph vessel stabilizing agent, wrinkle prevention/improvement agent, and edema improvement/prevention agent
JP2014530906A (en) * 2011-10-27 2014-11-20 株式会社アモーレパシフィックAmorepacific Corporation Skin improvement composition containing syringaresinol
US20140004210A1 (en) * 2012-06-28 2014-01-02 Shiseido Company, Ltd. Degradation inhibitor of hyaluronic acid, comprising rosemary extract and retinol acetate
US20200000704A1 (en) * 2012-06-28 2020-01-02 Shiseido Company, Ltd. Degradation inhibitor of hyaluronic acid, comprising rosemary extract and retinol acetate
CN117815216A (en) * 2019-04-19 2024-04-05 株式会社资生堂 Anti-photoaging and/or dermis pigmentation inhibitor
WO2022224619A1 (en) * 2021-04-23 2022-10-27 一丸ファルコス株式会社 Collagen production enhancer and topical skin agent including same
JP7166577B1 (en) * 2021-04-23 2022-11-08 一丸ファルコス株式会社 Collagen production promoter and external preparation for skin containing the same
CN113546014A (en) * 2021-07-26 2021-10-26 广州市百益康生物科技发展有限公司 Method for extracting dissolved tea polyphenol and Perilla oil and skin moistening oil thereof
CN113546014B (en) * 2021-07-26 2023-06-02 广州市百益康生物科技发展有限公司 Extraction method of dissolved tea polyphenol and Bos safflower fat and skin-moistening oil thereof

Also Published As

Publication number Publication date
JP4901024B2 (en) 2012-03-21

Similar Documents

Publication Publication Date Title
JP4901025B2 (en) Elastase inhibitor
JP5081354B2 (en) IgE production inhibitor
JP4901024B2 (en) 8-OHdG (8-hydroxydeoxyguanosine) production inhibitor
KR20090040344A (en) Topical skin compositions, their preparation, and their use
KR20090038460A (en) Topical skin compositions, their preparation, and their use
JP2004131500A (en) Skin aging inhibitor or improver
JPH0616531A (en) Cosmetic
JP4425163B2 (en) Anti-aging cosmetics
JPH09263534A (en) Promoter for melanogenesis
DE10329955A1 (en) Use of a hydroalcoholic extract from bauhinia for the preparation of a preparation
JPH06336419A (en) External agent for skin
JP2004115466A (en) Skin care preparation for external use
JP5771611B2 (en) Compositions and methods for skin repair
JP2001048773A (en) Cosmetic
KR20220079414A (en) Callus lysate comprising high content of callus metabolite and method of preparing therefor
KR20220112447A (en) Composition for improving skin, comprising Elaeaqnus macrophylla Extract as effective components, Cosmetic composition and Food functional composition including the same
JPH06336421A (en) External agent for skin
JPH06336422A (en) External agent for skin
JP2006008537A (en) External preparation for skin
EP2892526B1 (en) Composition comprising licoricidine
JP2016160181A (en) Make-up compositions, cosmetic compositions, compositions for joint protection, compositions
KR101686521B1 (en) Composition for beauty of skin
JP3591832B2 (en) External preparation for skin
JP3940633B2 (en) Topical skin preparation
JPH1179948A (en) Hair tonic and hair cosmetic, and preparation for external use for skin for suppressing sebum secretion

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080530

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20100726

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100928

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101129

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111004

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111125

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20111220

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111227

R150 Certificate of patent or registration of utility model

Ref document number: 4901024

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150113

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term